RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      베체트병의 심혈관 침범 환자의 재발에서 면역억제제의 효과 = Effect of Immunosuppressive Agents on Recurrence of Cardiovascular Involvement of Behcet`s Disease

      한글로보기

      https://www.riss.kr/link?id=A76550231

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objective: Despite the high risk for disease-related morbidity and mortality in Behcet`s disease (BD) with cardiovascular (CV) manifestations, only a few studies concerning BD with CV involvements are available. We conducted study to evaluate the clinical manifestations of CV BD (cardiovascular Behcet`s disease) and the clinical outcome according to the different treatment modalities, especially focusing on the immunosuppressive agents. Methods: We retrospectively reviewed 1,812 patients diagnosed with BD at tertiary hospital. All patients with vascular involvements were classified into three groups by lesion site. We assessed clinical characteristics, treatments, outcome and recurrence in each group. Results: Of 1,812 patients, 79 patients showed CV involvements. Male to female ratio was 65 (82.3%) to 14 (17.7%). Venous involvements occurred in 57 cases (72.2%), arterial lesions in 22 (27.8%), cardiac involvements 16 (20.3%). In clinical manifestation, only hypertension and arthritis were more frequently found in cardiac lesion than in venous lesion (p=0.01, p=0.01, respectively). CV lesions recurred in 16 patients (20.3%), mostly at the same sites as previous involvements. There was no association of recurrence with site of lesion (p=0.49). Recurrent rate was significant different in three medication group (p=0.028). Recurrences were more frequent in patients treated with no immunosuppressive agent and colchicines only or colchicines with prednisolone than in patients treated with additional immunosuppressive agent (p=0.024, R.R, 7.16 (95% CI, 1.55 to 32.99)). Conclusion: Recurrence rate was lower in patients with aggressive immunosuppressive treatment. Although most of patients improved, more efforts to decrease the relatively high rate of the recurrence (20.3%) would be needed.
      번역하기

      Objective: Despite the high risk for disease-related morbidity and mortality in Behcet`s disease (BD) with cardiovascular (CV) manifestations, only a few studies concerning BD with CV involvements are available. We conducted study to evaluate the clin...

      Objective: Despite the high risk for disease-related morbidity and mortality in Behcet`s disease (BD) with cardiovascular (CV) manifestations, only a few studies concerning BD with CV involvements are available. We conducted study to evaluate the clinical manifestations of CV BD (cardiovascular Behcet`s disease) and the clinical outcome according to the different treatment modalities, especially focusing on the immunosuppressive agents. Methods: We retrospectively reviewed 1,812 patients diagnosed with BD at tertiary hospital. All patients with vascular involvements were classified into three groups by lesion site. We assessed clinical characteristics, treatments, outcome and recurrence in each group. Results: Of 1,812 patients, 79 patients showed CV involvements. Male to female ratio was 65 (82.3%) to 14 (17.7%). Venous involvements occurred in 57 cases (72.2%), arterial lesions in 22 (27.8%), cardiac involvements 16 (20.3%). In clinical manifestation, only hypertension and arthritis were more frequently found in cardiac lesion than in venous lesion (p=0.01, p=0.01, respectively). CV lesions recurred in 16 patients (20.3%), mostly at the same sites as previous involvements. There was no association of recurrence with site of lesion (p=0.49). Recurrent rate was significant different in three medication group (p=0.028). Recurrences were more frequent in patients treated with no immunosuppressive agent and colchicines only or colchicines with prednisolone than in patients treated with additional immunosuppressive agent (p=0.024, R.R, 7.16 (95% CI, 1.55 to 32.99)). Conclusion: Recurrence rate was lower in patients with aggressive immunosuppressive treatment. Although most of patients improved, more efforts to decrease the relatively high rate of the recurrence (20.3%) would be needed.

      더보기

      참고문헌 (Reference)

      1 "an unusual manifestation of Behcet's disease" 438-40, jamsocechocardiogr1994;7

      2 "Vascular manifestations of Behcet's disease. Eighteen cases among 140 patients" 70 : 384-389, 2003

      3 "Vascular involvement in Behcet's disease" 402-10, jrheumatol1992;19

      4 "Vascular Manifestations in Behcet's Disease" 19 : 159-164, 2003

      5 "Valve prolapse in Behcet's disease" 100-1,

      6 "Treatment of Behcet's disease--an update" 30 : 299-312, 2001

      7 "The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center" 82 : 60-76, 2003

      8 "The clinical outcome and treatment in Behcet's disease with deep vein thrombosis" 528 : 495-501, 2003

      9 "Surgical treatment of vasculo-Behcet's disease. A review of patients with concomitant multiple aneurysms and venous lesions" 32 : 149-153, 2003

      10 "Surgical treatment of Behcet's disease involving aortic regurgitation" 68 : 2136-2140, 1999

      1 "an unusual manifestation of Behcet's disease" 438-40, jamsocechocardiogr1994;7

      2 "Vascular manifestations of Behcet's disease. Eighteen cases among 140 patients" 70 : 384-389, 2003

      3 "Vascular involvement in Behcet's disease" 402-10, jrheumatol1992;19

      4 "Vascular Manifestations in Behcet's Disease" 19 : 159-164, 2003

      5 "Valve prolapse in Behcet's disease" 100-1,

      6 "Treatment of Behcet's disease--an update" 30 : 299-312, 2001

      7 "The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center" 82 : 60-76, 2003

      8 "The clinical outcome and treatment in Behcet's disease with deep vein thrombosis" 528 : 495-501, 2003

      9 "Surgical treatment of vasculo-Behcet's disease. A review of patients with concomitant multiple aneurysms and venous lesions" 32 : 149-153, 2003

      10 "Surgical treatment of Behcet's disease involving aortic regurgitation" 68 : 2136-2140, 1999

      11 "Surgery for aortic regurgitation caused by Behcet's disease: a clinical study of 11 patients" 14 : 116-121, 1999

      12 "Rupture of abdominal aortic aneurysms in Behcet's disease" 17 : 682-685, 2003

      13 "Reoperation results of arterial involvement in Behcet's disease" 20 : 512-519, 2000

      14 "Recognition of the diverse cardiovascular manifestation in Behcet's disease" 457-8,

      15 "Pulmonary artery aneurysms in Behcet syndrome" 117 : 867-870, 2004

      16 "Management of aneurysms in Behcet's syndrome: an analysis of 24 patients" 121 : 150-156, 1997

      17 "Major vessel involvement in Behcet disease" 17 : 1-8, 2005

      18 "Long-term prognosis of arterial lesions of Behcet's disease" revmedinterne1993;14

      19 "Left ventricular aneurysm secondary to Behcet's disease" 131-2,

      20 "Is there a place for large vessel disease in the diagnostic criteria of Behcet's disease?" 26 : 2511-2512, 1999

      21 "Intracardiac thrombus in Behcet's disease: a systematic review" 118 : 479-487, 2000

      22 "Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Behcet's disease" 10 : 75-80, 2003

      23 "Endomyocardial fibrosis in Behcet's disease" 56 : 205-208, 1997

      24 "Deep vein thrombosis in Behcet's disease" 19 : S48-S50, 2001

      25 "Clinical manifestations of Behcet's disease: an analysis of 2147 patients" 38 : 423-427, 1997

      26 "Cardiovascular involvement in Behcet's disease" 43 : 389-398, 2002

      27 "Cardiovascular involvement in Behcet's disease" 64 : 542-551, 2003

      28 "Cardiac involvement in Behcet's disease" 12 2388-91,

      29 "Bilateral giant pulmonary artery aneurysms early in Behcet's disease" 24 : 1033-, 2003

      30 "Behcet-type vasculopathy in a patient without the diagnostic features of Behcet's disease" 39 : 1926-1930, 1996

      31 "Behcet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis" 686-7,

      32 "Behcet's disease with a large and free right atrial thrombus" 3 : 233-235, 2002

      33 "Behcet's aortitis mimicking aortic valve endocarditis with subaortic complications" 19 : 578-, 2006

      34 "Behcet's aortitis and aortic regurgitation: a report of two cases" 17 : 83-86, 2004

      35 "Arterial lesions in Behcet's disease. A study in 25 patients" 22 : 2103-2113, 1995

      36 "Arterial lesions in Behcet's disease" 32 : 75-81, 2003

      37 "Aortic valve involvement in Behcet's disease. A clinical study of 9 patients" 17 : 51-56, 2002

      38 "2-D and Doppler echocardiographic study in 65 patients with Behcet's syndrome" 638-41,

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2016-03-09 학회명변경 영문명 : The Korean Rheumatism Association -> Korean College of Rheumatology KCI등재
      2015-04-03 학술지명변경 외국어명 : The Journal of the Korean Rheumatism Association -> Journal of Rheumatic Diseases KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.1 0.1 0.08
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.08 0.09 0.242 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼